Skip to main content

Table 2 Logistic regression analysis of the correlation between FDC-SP expression and clinicopathological features

From: FDC-SP as a diagnostic and prognostic biomarker and modulates immune infiltrates in renal cell carcinoma

Characteristics

Total (N)

Odds ratio (OR)

p value

T stage (T3&T4 vs. T1&T2)

530

1.877 (1.312–2.699)

 < 0.001

N stage (N1 vs. N0)

255

3.289 (1.110–12.029)

0.044

M stage (M1 vs. M0)

498

2.733 (1.639–4.687)

 < 0.001

Age (> 60 vs. <  = 60)

530

1.163 (0.827–1.636)

0.385

Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II)

527

1.790 (1.257–2.556)

0.001

Gender (Male vs. Female)

530

0.847 (0.592–1.211)

0.363

Race (Asian&Black or African American vs. White)

523

0.863 (0.509–1.458)

0.583

Histologic grade (G3&G4 vs. G1&G2)

522

1.427 (1.011–2.018)

0.044

Laterality (Right vs. Left)

529

0.978 (0.695–1.376)

0.898